Ligand validation:6OIC

UQ1: UBIQUINONE-1

UQ1 is a Ligand Of Interest in 6OIC designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6OIC_UQ1_B_502	35%	10%	0.188	0.875	2.95	1.37	4	4	1	0	100%	1
6OIC_UQ1_A_503	34%	10%	0.197	0.88	2.87	1.51	4	4	2	0	100%	1
6OIC_UQ1_A_502	10%	10%	0.277	0.781	2.74	1.57	5	3	4	0	100%	1
6OIC_UQ1_A_504	3%	6%	0.307	0.651	2.77	2.39	4	5	4	0	100%	1
6WH6_UQ1_B_503	33%	10%	0.173	0.85	3.16	1.2	6	2	1	0	100%	1
6OI6_UQ1_A_502	11%	5%	0.282	0.803	2.84	2.55	4	6	1	0	100%	1
6OIB_UQ1_A_504	11%	13%	0.314	0.836	2.93	1.13	5	3	2	0	100%	1
2I5N_UQ1_L_502	73%	24%	0.114	0.941	2.03	1.09	2	2	0	0	100%	1
3G7F_UQ1_L_502	55%	20%	0.145	0.912	2.25	1.16	2	2	2	0	100%	1
8I07_UQ1_D_606	50%	8%	0.144	0.944	3.48	1.15	7	-	3	0	72%	0.7222
4TQQ_UQ1_L_304	44%	15%	0.211	0.94	1.95	1.79	7	4	11	0	100%	0.75

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.